Weekly Top News – IBD – February 24, 2020

filgotinib (GLPG0634) / GileadFilgotinib: Regulatory approval for ulcerative colitis in 2021 (Galapagos) - Feb 22, 2020 - FY 2019 Resultsbrazikumab (AMG 139) / AllerganOpen-label Extension Study of Brazikumab in Ulcerative Colitis (clinicaltrials.gov) - Feb 20, 2020 - P2; N=300; Not yet recruiting; Sponsor: AllerganHumira (adalimumab) / Eisai, AbbVieEfficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis (clinicaltrials.gov) - Feb 17, 2020 - P3; N=101; Completed; Sponsor: AbbVie; Active, not recruiting --> Completed